Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended...

Related Keywords

Delaware ,United States ,New Jersey ,Washington ,Mihaelh Polymeropoulos ,Kevin Moran ,Vanda Pharmaceuticals Inc ,Twitter ,Us Court ,Us District Court ,Prnewswire Vanda Pharmaceuticals Inc ,Exchange Commission ,Head Of Corporate Affairs ,Apotex Corp ,Teva Pharmaceuticals United States Inc ,Apotex Inc ,Hour Sleep Wake Disorder ,Teva Pharmaceuticals United States ,Federal Circuit ,New Drug Application ,Expanded Access ,Note Regarding Forward Looking ,Financial Condition ,Annual Report ,Quarterly Reports ,Current Reports ,Vice President ,Chief Financial Officer ,Corporate Affairs ,